FindMyKOL
Clinical trialNCT06018285RecruitingInterventional

Stepped Approach to Reducing Risk of Suicide in Primary Care

NCT06018285 is an interventional trial sponsored by Cynthia Fontanella. As of 21 Nov 2026, it is recruiting participants. It studies Suicidal Ideation, Suicide Prevention and 1 more condition. The registry lists an enrollment of 2,572 participants at 15 sites in 1 country. The registry lists a start date of 8 Aug 2023 and a primary completion date of 31 Jul 2027.

SponsorCynthia FontanellaEnrollment2,572Suicidal IdeationSuicide PreventionSuicide, Attempted
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT06018285
FieldValue
Registry IDNCT06018285
StatusRecruiting
Study typeInterventional trial
Lead sponsorCynthia Fontanella
Enrollment2,572
Registered sites15
Countries1
ConditionsSuicidal Ideation, Suicide Prevention and Suicide, Attempted
Start8 Aug 2023
Primary completion31 Jul 2027
Study completion31 Jul 2027
Last update posted8 Aug 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Suicide is the second leading cause of death among young people aged 12-17 years in the United States, yet many youth at risk for suicide are not identified or go untreated. Stepped care approaches have been shown to be effective at reducing suicide risk in clinical settings, including primary care. The goal of this hybrid I stepped wedge effectiveness-implementation study is to test the effectiveness of a population-based quality improvement (QI) intervention, entitled STARRS-PC (Stepped Approach to Reducing Risk of Suicide in Primary Care) compared to treatment as usual (TAU), in reducing the risk of suicidal behavior among youth in the pediatric primary care setting. STARRS-PC implements a clinical pathway for youth at elevated risk for suicide in pediatric primary care clinics. Clinical pathways are tools used by health professionals to guide evidence-informed practice. The STARRS-PC pathway consists of three evidence-based suicide clinical care processes: risk detection, assessment and triage, and, if needed, follow-up transitional care. STARRS-PC is guided by the Practical, Robust Implementation, and Sustainability Model (PRISM), which allows for the study of factors that influence effective implementation of the suicide prevention clinical pathway and is focused on scalability. The main questions the study aims to answer are: * Will STARRS-PC be more effective than TAU at reducing the rate of suicide attempt at 12 months post-baseline (primary outcome)? * Will STARRS-PC be more effective than TAU at reducing suicidal ideation and non-suicidal self-injury, and improving family satisfaction at 12 months post-baseline (secondary outcomes)? * What are the barriers and facilitators of effective implementation and sustainability of STARRS-PC?

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States15 sites, 12 recruiting
  • Axesspointe Community Health Centers/health Quarters

    Akron

    Recruiting
  • Signature Health

    Ashtabula

    Recruiting
  • Holzer Health System

    Athens

    Recruiting
  • Nationwide Children's Hospital

    Columbus

    Alex Kemper, MD, MPH, MSJeffrey Bridge, PhDJennifer Hughes, PhD, MPH
    Not, yet, recruiting
  • Dayton Children's Hospital - Hope Center

    Dayton

    Recruiting
  • Dayton Children's Hospital - Main

    Dayton

    Recruiting
  • Holzer Health System

    Gallipolis

    Recruiting
  • Hilliard Pediatrics

    Hilliard

    Recruiting
  • Holzer Health System

    Jackson

    Recruiting
  • Maumee Pediatric Associates

    Maumee

    Recruiting
  • Cornerstone Pediatrics

    Miamisburg

    Recruiting
  • Signature Health

    Painesville

    Recruiting
  • Village Square Primary Care Center

    Perrysburg

    Not, yet, recruiting
  • Franklin Avenue Primary Care Center

    Toledo

    Terminated
  • Signature Health

    Willoughby

    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 15 sites, 12 recruitingOH15PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT06018285

Each answer restates registry values shown on this page.

What is NCT06018285?

NCT06018285 is an interventional trial sponsored by Cynthia Fontanella. It studies Suicidal Ideation, Suicide Prevention and 1 more condition.

Is NCT06018285 recruiting?

As of 21 Nov 2026, it is recruiting participants. 12 of its 15 sites list their own status as recruiting.

Who leads NCT06018285?

The registry names Alex Kemper, MD, MPH, MS (principal investigator, Abigail Wexner Research Institute at NCH), Cynthia Fontanella, PhD (study director, Abigail Wexner Research Institute at NCH), Jeffrey Bridge, PhD (principal investigator, Abigail Wexner Research Institute at NCH) and 1 more official as overall officials.

Where does NCT06018285 run?

The registry lists 15 sites in 1 country. Every site with a stated country is in one country: United States.

When is NCT06018285 expected to complete?

The registry lists a primary completion date of 31 Jul 2027 and a study completion date of 31 Jul 2027. The sponsor last updated the record on 8 Aug 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.